The University of Southampton
University of Southampton Institutional Repository

The prevention of diabetes and cardiovascular disease in people with schizophrenia

The prevention of diabetes and cardiovascular disease in people with schizophrenia
The prevention of diabetes and cardiovascular disease in people with schizophrenia
Objective
Primary prevention of diabetes and cardiovascular disease is an important priority for people with schizophrenia. This review aims to identify lifestyle and pharmacological interventions that reduce diabetes and cardiovascular disease in people with schizophrenia.

Method
PubMed and other electronic databases were searched to identify relevant articles.

Results
Lifestyle interventions that focus on diet and physical activity reduce the incidence of diabetes. Similar programmes in people with schizophrenia have led to significant weight loss and may reasonably be expected to reduce diabetes in the long-term. Metformin may be considered when lifestyle change is not feasible or effective. Lifestyle interventions, particularly smoking cessation, are likely to be effective in reducing cardiovascular disease in people with schizophrenia. Although cardiovascular prevention trials with statins have not been performed in people with schizophrenia, similar reductions in cholesterol has been seen as in the general population and statins should be considered for those at high risk. Traditional cardiovascular risk prediction models perform well in identifying those at high cardiovascular risk, but bespoke prediction models using data from people with schizophrenia perform better.

Conclusion
Reducing diabetes and cardiovascular disease requires a coordinated and concerted effort from mental and physical health teams working across primary and secondary care.
diabetes, cardiovascular disease, prevention, screening, schizophrenia
86-96
Holt, R.I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Holt, R.I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393

Holt, R.I.G. (2015) The prevention of diabetes and cardiovascular disease in people with schizophrenia. [in special issue: Promotion of Physical Health and Wellbeing in Persons with Schizophrenia] Acta Psychiatrica Scandinavica, 132 (2), 86-96. (doi:10.1111/acps.12443).

Record type: Article

Abstract

Objective
Primary prevention of diabetes and cardiovascular disease is an important priority for people with schizophrenia. This review aims to identify lifestyle and pharmacological interventions that reduce diabetes and cardiovascular disease in people with schizophrenia.

Method
PubMed and other electronic databases were searched to identify relevant articles.

Results
Lifestyle interventions that focus on diet and physical activity reduce the incidence of diabetes. Similar programmes in people with schizophrenia have led to significant weight loss and may reasonably be expected to reduce diabetes in the long-term. Metformin may be considered when lifestyle change is not feasible or effective. Lifestyle interventions, particularly smoking cessation, are likely to be effective in reducing cardiovascular disease in people with schizophrenia. Although cardiovascular prevention trials with statins have not been performed in people with schizophrenia, similar reductions in cholesterol has been seen as in the general population and statins should be considered for those at high risk. Traditional cardiovascular risk prediction models perform well in identifying those at high cardiovascular risk, but bespoke prediction models using data from people with schizophrenia perform better.

Conclusion
Reducing diabetes and cardiovascular disease requires a coordinated and concerted effort from mental and physical health teams working across primary and secondary care.

Full text not available from this repository.

More information

Accepted/In Press date: 23 April 2015
e-pub ahead of print date: 15 May 2015
Published date: August 2015
Keywords: diabetes, cardiovascular disease, prevention, screening, schizophrenia
Organisations: Faculty of Medicine

Identifiers

Local EPrints ID: 380220
URI: http://eprints.soton.ac.uk/id/eprint/380220
PURE UUID: 795d701a-a908-4f93-829a-54f0d8692904
ORCID for R.I.G. Holt: ORCID iD orcid.org/0000-0001-8911-6744

Catalogue record

Date deposited: 07 Sep 2015 13:14
Last modified: 18 Feb 2021 16:56

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×